Login
Create Account
  • Current Issue
  • Archive
  • Departments
  • Subspecialties
  • About
    About AAOS Now Advertising Submissions Editorial Board and Staff Contact the Editor About AAOS Headline News Now AAOS Now Daily Edition
Renew Your Membership by January 1 to Maintain Access to Exclusive Cutting-Edge Resources.

AAOS Now / Issue

AAOS Now, Aug-Sept 2025

Annual Meeting Your AAOS Clinical Quality & Research Practice Management Professional Development Advocacy Residency Biologics Commentary
  • Data review presents geniculate artery embolization as an emerging minimally invasive technique for knee OA

    Ajay Srivastava, MD, FAAOS; Mohammed Alsarraj, MD; Kevin Adik, MD; Abdullah Alsarraj, BS

    Osteoarthritis is characterized by the breakdown of articular cartilage, subchondral bone remodeling, osteophyte formation, and synovial inflammation, which leads to chronic pain and reduced quality of life.

  • Opioid stewardship: Simple pain-management strategies decrease the risk of opioid abuse after orthopaedic surgery

    Asif Ilyas, MD, MBA, FAAOS

    Substance use disorder, particularly related to opioid abuse, is an aspect of mental health that orthopaedic surgeons must be aware of anytime they consider pain-management options.

  • Integrating mental health tools into the clinical workflow helps support orthopaedic patients, improve outcomes

    Leslie Schwindel, MD, FAAOS

    Chronic pain and psychiatric disorders are common comorbidities in orthopaedic patients and often contribute to treatment outcomes regardless of the subspecialty.

  • Evidence-based guidelines needed for perioperative antithrombotic management in TJA

    Theodor Di Pauli von Treuheim, MD; Benjamin Padon, BS; Anzar Sarfraz, MD; Garrett Ruff, BS; Vinay K. Aggarwal, MD

    Patients taking antithrombotic medications present a unique challenge in total joint arthroplasty, as their baseline risk for both hemorrhagic and thromboembolic events is elevated.

  • OVT video walks through endoscopic shelf acetabuloplasty with labral repair for management of acetabular dysplasia

    Ahmed Emara, MD

    Hip dysplasia has traditionally been considered a contraindication for arthroscopic procedures, including labral repair, due to acetabular under-coverage driving labral damage.

  • Sponsored Video: An enhanced innovation in a legacy of proven protection

    Ioban™ CHG Chlorhexidine Gluconate Incise Drape (contains 2% w/w CHG) is a cost-effective solution to help reduce the risk of surgical site infections, making it a prudent choice for your surgical procedures.

Please log in.

Some AAOS Now articles are available only to AAOS members. Please log in to access this article.

 
Not a member? Become a member.

  • 9400 West Higgins Road

    Rosemont, Illinois 60018

    Phone: 847.823.7186

    Fax: 847.823.8125

    • About AAOS
    • Online Learning
    • Clinical Practice Guidelines
    • Career Center
    • Newsroom
    • Find an Orthopaedist
    • Contact Us
    • Corporate Engagement
    • Join the AAOS Team
    • Privacy Policy
    • Terms of Use
    • Code of Conduct

© 1995-2025 by the American Academy of Orthopaedic Surgeons. "All Rights Reserved." This website and its contents may not be reproduced in whole or in part without written permission. "American Academy of Orthopaedic Surgeons" and its associated seal and "American Association of Orthopaedic Surgeons" and its logo are all registered U.S. trademarks and may not be used without written permission.